FIELD: medicine, oncology, protein chemistry. SUBSTANCE: retroplacental or abortive serum is tested, frozen and frozen out before onset of alpha-fetoprotein isolation followed by centrifugation. Then ammonium sulfate saturated solution is added to supernatant up to 30% of saturation, centrifuged again, crystalline ammonium sulfate is added to supernatant up to 70% of saturation and centrifuged. Obtained precipitate is dissolved in 10 mM sodium phosphate solution, pH 7.3, dialyzed, centrifuged and purified by affinity, ion-exchange and gel-exclusive chromatography followed by concentrating the purified alpha-fetoprotein to 1.5-5.0 mg/ml. Then the conjugation of alpha-fetoprotein (concentration is 1.5-2.0 mg/ml) with 2,3,7,8-tetrachlorodibenzo-p-dioxine dissolved in dioxane is carried out followed by addition of mannitol up to the concentration 5%, lyophilic drying, hermetic package under inert gas atmosphere and storage at -70 C. Invention can be used in chemotherapy of oncological patients. EFFECT: enhanced effectiveness of suppression of cancer cells proliferation of hormone-dependent organs and tissues. 1 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING ACTIVE FRAGMENT OF HUMAN ALPHA-FETOPROTEIN | 2010 |
|
RU2448116C2 |
ANTI-TUMOUR PREPARATION | 2011 |
|
RU2451509C1 |
METHOD OF OBTAINING RADIOLABELLED WITH RADIONUCLIDES ALPHA-FETOPROTEIN IODINE AND METHOD OF ITS IMPLEMENTATION FOR DIAGNOSTICS OF MALIGNANT TUMORS | 2009 |
|
RU2404812C1 |
ANTITUMOR PEPTIDE PREPARATION BASED ON ALPHA-FETOPROTEIN FRAGMENT, ITS CONJUGATE, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF HORMONE-DEPENDENT TUMORS | 2005 |
|
RU2285537C1 |
METHOD OF PREPARING THE PREPARATION FOR THE DIRECTED DELIVERY OF ANTITUMOR DRUG IN CANCER CELLS | 1996 |
|
RU2097060C1 |
CONJUGATE OF BIOLOGICALLY ACTIVE SUBSTANCES WITH $$$-FETOPROTEIN SHOWING THE SELECTIVE ACTION WITH RESPECT TO CANCER TUMORS, METHOD OF THEIR PREPARING (VARIANTS) AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1996 |
|
RU2071351C1 |
CONJUGATE OF ANTITUMOUR DRUGS WITH RECOMBINANT ALPHA-FETOPROTEIN AND ITS FUNCTIONAL FRAGMENTS AND METHOD OF THEIR PRODUCING | 2016 |
|
RU2630974C1 |
PEPTIDE REPRESENTING ANALOG OF ALPHA-FETOPROTEIN FRAGMENT, CONJUGATE OF PEPTIDE WITH DOXORUBICIN AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF FOR TREATMENT OF ONCOLOGY DISEASE | 2006 |
|
RU2317102C1 |
METHOD OF ALPHA-FETOPROTEIN PREPARATION PREPARING | 1998 |
|
RU2123009C1 |
METHOD FOR PREPARING ALPHA-FETOPROTEIN PREPARATION TABLET | 2005 |
|
RU2319479C2 |
Authors
Dates
1999-10-10—Published
1998-01-22—Filed